Givaudan partners with Michigan State University and PitFit to test the performance benefits of Cereboost™

Givaudan, the global leader in taste and wellbeing, has announced the results of an open-label clinical study, conducted with Michigan State University (MSU) and PitFit Inc, a premier training facility for professional racecar drivers in Indianapolis, Indiana, U.S. The study used state-of-the-art tools to, in part, assess the impact of Cereboost™, Givaudan’s patented American ginseng extract, on the drivers’ reaction time.

Notable improvements in driving performance with Cereboost^TM

The study revealed notable improvements in driving performance among drivers who took Cereboost^TM for two weeks, including a significant reduction in the fastest lap time (3 seconds) and significantly faster throttle application on corners.

After taking Cereboost,^TM participating drivers also reported in a subjective questionnaire feeling positive effects:

• 94% agreed Cereboost™ effectively enhanced their focus
• 91% perceived the effects faster than other products they have tried in the past

Jim Leo, CEO of PitFit, commented: “As the industry leader in human performance coaching for motorsports, PitFit has always taken a proactive approach to researching anything that might improve our clients’ performance. Given our strong interest in supporting drivers’ performance, we began exploring research on nutritional supplements that could assist us in our quest. Cereboost^TM was an obvious choice, as it’s backed by peer-reviewed research to support attention and focus.”

Cereboost™: think faster, perform better

“Working with Michigan State University and PitFit gave us the opportunity to evaluate the real-world benefits of an already clinically studied ingredient and understand how athlete drivers perceived its effect, getting us closer to understanding consumer perception” said Romain Le Cozannet, Mind & Energy Category Technical Leader at Givaudan Taste & Wellbeing.

^[1] White D.J. et al. (2020) ‘Effects of Panax quinquefolius (American ginseng) on the steady state visually evoked potential during cognitive performance’, Human Psychopharmacology, Clinical and Experimental, 35(6):1-6.

^[2] Bell L, et al. (2022) ‘A randomized, placebo-controlled trial investigating the acute and chronic benefits of American Ginseng (Cereboost®) on mood and cognition in healthy young adults, including in vitro investigation of gut microbiota changes as a possible mechanism of action’, European Journal of Nutrition, 61(1):413-428.

^[3] Ossoukhova A. et al. (2015) ‘Improved working memory performance following administration of a single dose of American ginseng (Panax quinquefolius L.) to healthy middle-age adults’, Human Psychopharmacology, Clinical and Experimental, 30(2):108-122.

^[4] Shin K. (2016) ‘Cereboost™, an American Ginseng extract, improves cognitive function via up-regulation of choline acetyltransferase expression and neuroprotection’, Regulatory Toxicology and Pharmacology, 78:53-8.